Oxford MEStar
Oxford MEStar is a company focused on translational and regenerative medicine, dedicated to developing innovative technologies and providing bioengineering solutions. It specializes in creating products and services for the translational and regenerative medicine industry, particularly in the areas of stem cell processing, engineered tissue manufacturing, and cellular bioproducts. The company possesses significant technical expertise in bioprocessing, bioengineering, and bio-manufacturing, allowing it to offer advanced solutions such as 3D bioprinting and in-vitro diagnostic development. Oxford MEStar also facilitates technology transfer between the UK and China, enhancing collaboration in the field of regenerative medicine.
Top Stages
1 past transactions
MODE Diagnostics
Acquisition in 2016
Mode Diagnostics is focused on developing innovative diagnostic products for bowel cancer screening. The company leverages the electrochemical properties of biomarkers to create novel assays suited for both physician offices and consumer self-testing. Its advanced suite of technologies includes assay development techniques, biosensing capabilities, microfabrication, electronics, and wireless communications. Mode's proprietary platform, measure, is designed to be flexible, low-cost, and hygienic, allowing for the easy configuration of health tests. The company's initial product, measure BOWEL HEALTH, significantly enhances existing methods for fecal occult blood testing, representing a notable advancement in bowel cancer screening. Through its user-friendly and medically informative health screening products, Mode Diagnostics aims to improve the efficiency of bowel cancer detection for healthcare providers and consumers alike.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.